Изследователски екипи

Последно актуализиране :
27/11/2024

Изследователски екипи - University of Michigan, College of Pharmacy

University of Michigan, College of Pharmacy

Ann Arbor

cejohn@umich.edu

Библиография

(56)

Stability of i.v. admixture containing metoclopramide, diphenhydramine hydrochloride, and dexamethasone sodium phosphate in 0.9% sodium chloride injection
Kintzel P.E, Zhao T, Wen B, Sun D. ( (polly.kintzel@spectrumhealth)
Am J Health-Syst Pharm - 2014 - ; 71:2061-2065

Stability of an extemporaneously prepared thalidomide suspension.
Kraft S, . Johnson C.E, Tyler R.P. (svandeko@med.umich.edu)
Am J Health-Syst Pharm - 2012 - ; 69:56-58.

Extended stability of intravenous acetaminophen in syringes and opened vials.
Kwiatkowski J.L, Johnson C.E, Wagner D.S. (debbiew@umich.edu)
Am J Health-Syst Pharm - 2012 - ; 69:1999-2001

Stability of extemporaneously prepared acetylcysteine 1% and 10% solutions for treatment of meconium ileus
Fohl AL, Johnson CE, Cober P. (cejohn@umich.edu)
Am J Health-Syst Pharm - 2011 - ; 68: 69-72.

Stability of extemporaneously prepared oxandrolone oral suspensions.
Johnson CE, Cober MP, hawkins KA, Julian JD. (cejohn@umich.edu)
Am J Health-Syst Pharm - 2011 - ; 68:519-521.

Stability of an extemporaneous alcohol-free melatonin suspension.
Johnson CE, Cober MP, Thome T, Rouse E. (cejohn@umich.edu)
Am J Health-Syst Pharm - 2011 - ; 68:420-423.

Stability of extemporaneously prepared rifaximin oral suspensions.
Cober MP, Johnson CE, Lee J, Currie K. (mcober@umich.edu)
Am J Health-Syst Pharm - 2010 - ; 67: 287-289.

Stability of extemporaneously prepared moxifloxacin oral suspensions
Hutchinson DJ, Johnson CE, Klein KC. (cejohn@umich.edu)
Am J Health-Syst Pharm - 2009 - ; 66: 665-667.

Stability of metoprolol tartrate injection 1 mg/ml undiluted and 0.5 mg/ml in 0.9% sodium chloride injection and 5% dextrose injection.
Kraft MD, Johnson CE, Chung C, Julian F. (cejohn@umich.edu)
Am J Health-Syst Pharm - 2008 - ; 65, 7: 636-638.

Stability of a flavored formulation of acetylcysteine for oral administration
Siden R, Johnson CE. ()
Am J Health-Syst Pharm - 2008 - ; 65: 558-561.

Stability of vecuronium in sterile water for injection stored in polypropylene syringes for 21 days.
Johnson CE, Petrea Cober M. (cejohn@umich.edu)
Am J Health-Syst Pharm - 2007 - ; 64, 22: 2356-2358.

Stability of 70% alcohol solutions in polypropylene syringes for use in ethanol-lock therapy.
Cober M.P, Johnson C.E. ()
Am J Health-Syst Pharm - 2007 - ; 64, 23: 2480-2482.

Stability of extemporaneously prepared sodium phenylbutyrate oral suspensions
Caruthers RL, Johnson CE. (cejohn@umich.edu)
Am J Health-Syst Pharm - 2007 - ; 64: 1513-1515.

Stability of an extemporaneously prepared alcohol-free phenobarbital suspension
Cober MP, Johnson CE. (cejohn@umich.edu)
Am J Health-Syst Pharm - 2007 - ; 64: 644-646.

Stability of partial doses of omeprazole-sodium bicarbonate oral suspension.
Johnson CE, Cober MP, Ludwig JL. (cejohn@umich.edu)
Ann Pharmacotherapy - 2007 - ; 41: 1954-1961.

Stability of pantoprazole in 0.9% sodium chloride injection in polypropylene syringes.
Johnson CE. (cejohn@umich.edu)
Am J Health-Syst Pharm - 2005 - ; 62: 2410-2412.

Stability of anhydrous theophylline in extemporaneously prepared alcohol-free oral suspensions.
Johnson CE, vanDe Koppel S, Myers E. (cejohn@umich.edu)
Am J Health-Syst Pharm - 2005 - ; 62: 2518-2520.

Stability of tramadol hydrochloride--acetaminophen (Ultracet) in strawberry syrup and in a sugar-free vehicle
Johnson CE, Wagner DS, DeLoach SL, Cichon-Hensley BK. (cejohn@umich.edu)
Am J Health-Syst Pharm - 2004 - ; 61: 54-57.

Stability of oral liquid preparations of tramadol in strawberry syrup and a sugar-free vehicle
Wagner DS, Johnson CE, Cichon-Hensley BK, DeLoach SL. (cejohn@umich.edu)
Am J Health-Syst Pharm - 2003 - ; 60: 1268-1270.

Stability of flucytosine 50 mg/mL in extemporaneous oral liquid formulations
VandenBussche HL, Johnson CE, Yun J, Patel SA. (cejohn@umich.edu)
Am J Health-Syst Pharm - 2002 - ; 59: 1853-1855.

Stability of oral suspensions of ursodiol made from tablets
Johnson CE, Streetman DD. (cejohn@umich.edu)
Am J Health-Syst Pharm - 2002 - ; 59: 361-363.

Stability of flucytosine 50 mg/mL in extemporaneous oral liquid formulations
VandenBussche HL, Johnson CE, Yun J, Patel SA. (cejohn@umich.edu)
Am J Health-Syst Pharm - 2002 - ; 59: 1853-1855.

Stability of norfloxacin in an extemporaneously prepared oral liquid
Johnson CE, Price J, Hession JM. (cejohn@umich.edu)
Am J Health-Syst Pharm - 2001 - ; 58: 577-579.

Stability of tacrolimus with morphine sulfate, hydromorphone hydrochloride, and ceftazidime during simulated intravenous coadministration.
Johnson CE, VandenBussche HL, Chio CC, Jacobson PA. (cejohn@umich.edu)
Am J Health-Syst Pharm - 1999 - ; 56: 164-169.

Stability and compatibility of tacrolimus and fluconazole in 0.9% sodium chloride.
Johnson CE, Truong NM. (cejohn@umich.edu)
J Am Pharm Assoc - 1999 - ; 39: 505-509.

Stability of levofloxacin in an extemporaneously compounded oral liquid
VandenBussche HL, Johnson CE, Fontana EM, Meram JM. (cejohn@umich.edu)
Am J Health-Syst Pharm - 1999 - ; 56: 2316-2318.

Stability of ciprofloxacin in an extemporaneous oral liquid dosage form.
Johnson CE, Wong D, Hoppe HL, Bhatt-Mehta V. ()
Int J Pharm Compound - 1998 - ; 2, 4: 314-317.

Stability of torsemide in 5% dextrose injection.
Montgomery PA, Cornish LA, Johnson CE, Fitzpatrick KA. (cejohn@umich.edu)
Am J Health-Syst Pharm - 1998 - ; 55: 1042-1043.

Physical compatibility and chemical stability of atracurium besylate and midazolam hydrochloride during intravenous coinfusion.
Bhatt-Mehta V, Hirata S. ()
Int J Pharm Compound - 1998 - ; 2: 79-81.

Stability of ciprofloxacin in an extemporaneous oral liquid dosage form.
Johnson C.E, Wong D.V, Hoppe H.L, Bhatt-Mehta V. ()
Int J Pharm Compound - 1998 - ; 2: 314-317.

Compatibility of bupivacaine hydrochloride and morphine sulfate.
Johnson CE, Christen C, Perez MM, Ma M. (cejohn@umich.edu)
Am J Health-Syst Pharm - 1997 - ; 54: 61-64.

Stability of bumetanide in 5% dextrose injection.
Cornish LA, Montgomery PA, Johnson CE. (cejohn@umich.edu)
Am J Health-Syst Pharm - 1997 - ; 54: 422-423.

Stability of tacrolimus in an extemporaneously compounded oral liquid
Jacobson PA, Johnson CE, West NJ, Foster JA. (cejohn@umich.edu)
Am J Health-Syst Pharm - 1997 - ; 54: 178-180.

Stability of bupivacaine hydrochloride and hydromorphone hydrochloride during simulated epidural coadministration.
Christen C, Johnson CE, Walters JR. (cejohn@umich.edu)
Am J Health-Syst Pharm - 1996 - ; 53: 170-173.

Stability of propofol with parenteral nutrient solutions during simulated Y-site injection.
Bhatt-Mehta V, Paglia RE, Rosen DA. ()
Am J Health-Syst Pharm - 1995 - ; 52: 192-196.

Stability of fentanyl citrate and midazolam hydrochloride during simulated intravenous coadministration.
Bhatt-Mehta V, Johnson CE, Leininger N, Agarwal M. (cejohn@umich.edu)
Am J Health-Syst Pharm - 1995 - ; 52: 511-513.

Stability of itraconazole in an extemporaneously compounded oral liquid
Jacobson PA, Johnson CE, Walters, JR. (cejohn@umich.edu)
Am J Health-Syst Pharm - 1995 - ; 52: 189-191.

Stability of ursodiol in an extemporaneously compounded oral liquid
Johnson CE, Nesbitt J. (cejohn@umich.edu)
Am J Health-Syst Pharm - 1995 - ; 52: 1798-1800.

Stability of ganciclovir sodium and amino acids in parenteral nutrient solutions.
Johnson CE, Jacobson PA, Chan E. ()
Am J Hosp Pharm - 1994 - ; 51: 503-508.

Stability of midazolam hydrochloride and morphine sulfate during simulated intravenous coadministration.
Johnson CE, Bhatt-Mehta V, Mancari SC, McKown JA. (cejohn@umich.edu)
Am J Hosp Pharm - 1994 - ; 51: 2812-2815.

Stability of isradipine in an extemporaneously compounded oral liquid
MacDonald JL, Johnson CE, Jacobson P. (cejohn@umich.edu)
Am J Hosp Pharm - 1994 - ; 51: 2409-2411.

Stability of mesalamine in rectal suspension diluted with distilled water
Henderson LM, Johnson CE, Berardi RR. (cejohn@umich.edu)
Am J Hosp Pharm - 1994 - ; 51: 2955-2957.

Stability and compatibility of fluconazole and aminophylline in intravenous admixtures.
Johnson CE, Jacobson PA, Pillen HA, Woycik CL. (cejohn@umich.edu)
Am J Hosp Pharm - 1993 - ; 50: 703-706.

Stability of an extemporaneously compounded baclofen oral liquid
Johnson CE, Hart SM. (cejohn@umich.edu)
Am J Hosp Pharm - 1993 - ; 50: 2353-2355.

Stability of fluconazole and amino acids in parenteral nutrient solutions.
Couch P, Jacobson P, Johnson CE. (cejohn@umich.edu)
Am J Hosp Pharm - 1992 - ; 49: 1459-1462.

Stability of ceftazidime and tobramycin sulfate in peritoneal dialysis solution
Mason NA, Johnson CE, O'Brien MA. (cejohn@umich.edu)
Am J Hosp Pharm - 1992 - ; 49: 1139 - 1142.

Stability of an extemporaneously compounded clonidine hydrochloride oral liquid
Levinson ML, Johnson CE. (cejohn@umich.edu)
Am J Hosp Pharm - 1992 - ; 49: 122-125.

Stability of an extemporaneously compounded terbutaline sulfate oral liquid
Horner RK, Johnson CE. (cejohn@umich.edu)
Am J Hosp Pharm - 1991 - ; 48: 293-295.

Stability of imipenem and cilastatin sodium in total parenteral nutrient solution.
Zaccardelli DS, Sanders Kromarik C, Wolk R, Khalidi N. ()
JPEN - 1990 - ; 14: 306-309.

Compatibility of aminophylline and verapamil in intravenous admixtures.
Johnson CE, Lloyd CW, Mesaros JL, Rubley GJ. (cejohn@umich.edu)
Am J Hosp Pharm - 1989 - ; 46: 97-100.

Compatibility of premixed theophylline and verapamil intravenous admixtures.
Johnson CE, Lloyd CW, Aviles AI, Rybarz KL. (cejohn@umich.edu)
Am J Hosp Pharm - 1988 - ; 45: 609-612.

Compatibility of premixed theophylline and methylprednisolone sodium succinate intravenous admixtures.
Johnson CE, Cohen IA, Michelini TJ, McMahon RE. (cejohn@umich.edu)
Am J Hosp Pharm - 1987 - ; 44: 1620-1624.

Compatibility of aminophylline and methylprednisolone sodium succinate intravenous admixtures.
Johnson CE, Cohen IA, Craft DA, Lizer MH. ()
Am J Hosp Pharm - 1986 - ; 43: 1482-1485.

Stability of trimethoprim-sulfamethoxazole injection in five infusion fluids.
Deans KW, Lang JR, Smith DE. ()
Am J Hosp Pharm - 1982 - ; 39: 1681-1684.

Factors affecting diazepam infusion: solubility, administration-set composition, and flow rate.
Mason NA, Cline S, Hyneck ML, Berardi RR, Ho NFH, Flynn GL. ()
Am J Hosp Pharm - 1981 - ; 38: 1449-1454.

молекули изследвани

(55)

		5 aminosalicylic acid
		Aminophylline
		Atracurium besylate
		Baclofen
		Bumetanide
		Bupivacaine hydrochloride
		Ceftazidime
		Ciprofloxacin hydrochloride
		Clonidine hydrochloride
		Co-trimoxazole
		Dexamethasone sodium phosphate
		Diazepam
		Diphenhydramine hydrochloride
		Ethanol
		Fentanyl citrate
		Fluconazole
		Flucytosine
		Ganciclovir sodium
		Heparin sodium
		Hydromorphone hydrochloride
		Imipenem - cilastatin sodium
		Isradipine
		Itraconazole
		Levofloxacine
		Melatonine
		Methylprednisolone sodium succinate
		Metoclopramide hydrochloride
		Metoprolol tartrate
		Midazolam hydrochloride
		Morphine sulfate
		Moxifloxacin
		N-acetylcysteine
		Norfloxacine
		Omeprazole sodium
		Oxandrolone
		Pantoprazole sodium
		Paracetamol
		Paracetamol
		Phenobarbital
		Phenylbutyrate sodium
		Propofol
		Rifaximin
		Sodium citrate
		Tacrolimus
		Tacrolimus
		Terbutaline sulfate
		Thalidomide
		Theophylline
		Theophylline
		Tobramycin sulfate
		Torsemide
		Tramadol hydrochloride
		Ursodesoxycholique acid
		Vecuronium bromide
		Verapamil hydrochloride

Mentions Légales